Christopher Lieu

Associate Professor

University of Denver

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Christopher Lieu is an Associate Professor at the University of Colorado Denver in the United States. His research focuses on oncology, specifically examining topics such as colorectal cancer, cancer service lines, and the application of artificial intelligence in clinical decision-making. Recent publications include studies on genomic landscapes and innovative clinical trials in cancer therapeutics.

Articles (17)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2020

Collaborators (11)

Lauren Fishbein

University of Colorado School of Medicine

UNITED STATES

View details

Laura Graham

Assistant Professor

University of Colorado Boulder

UNITED STATES

View details

Thomas J George

University of Florida

UNITED STATES

View details

Richard Adams

Professor

Cardiff University

UNITED KINGDOM

View details

Robert Lentz

Assistant Professor

University of Colorado Cancer Center

UNITED STATES

View details

Amit Mahipal

University Hospitals Seidman Cancer Center

UNITED STATES

View details

Eric Konnick

Associate Professor

University of Washington

UNITED STATES

View details

Patrick M. Forde

Johns Hopkins University

UNITED STATES

View details

Alexis Leal

Assistant Professor of Medicine

University of Colorado Anschutz Medical Campus

UNITED STATES

View details

Nicole Simone

Professor; Program Leader SKCC; Vice Chair for Research, Faculty Development and DEI

Sidney Kimmel Medical College at Thomas Jefferson University

UNITED STATES

View details

Shaikh Atif

Assistant Professor

University of Colorado Anschutz Medical Campus

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Christopher Lieu

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

Benchmarking the Current Landscape: Insights From an Association of American Cancer Institutes Survey on Academic Cancer Service Lines

A First-In-Human Dose-Escalation Phase 1 Study of Basroparib (STP1002), a Tankyrase Inhibitor, in Patients with Advanced-Stage Solid Tumors

Response to Biologics in Patients With Early-Onset Treatment-Naïve Metastatic Colorectal Cancer—An Aide et Recherche en Cancérologie Digestive Database Analysis

Squamous cell carcinoma of unknown primary (SCCUP): a genomic landscape study

Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group

Genomic Landscapes of Early-Onset Versus Average-Onset Colorectal Cancer Populations

Risk Without Reward: Differing Patterns of Chemotherapy Use Do Not Improve Outcomes in Stage II Early-Onset Colon Cancer

Using Artificial Intelligence to Support Informed Decision-Making on BRAF Mutation Testing

Toward optimizing patient selection for EGFR antibody therapies in metastatic colorectal cancer: outcomes and resistance features in real-world data

Pancreatic ductal adenocarcinoma cells regulate NLRP3 activation to generate a tolerogenic microenvironment

Pulmonary metastasectomy is associated with survival after lung-only recurrence in pancreatic cancer

Early-Onset GI Cancers: Rising Trends, Genetic Risks, Novel Strategies, and Special Considerations

Podcast article: Biomarker testing in colorectal cancer

First-in-Human Dose-Escalation Study of the Novel Oral Depsipeptide Class I-Targeting HDAC Inhibitor Bocodepsin (OKI-179) in Patients with Advanced Solid Tumors

Case of Metastatic Pheochromocytoma and Meningiomas in a Patient With Lynch Syndrome

Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial

Safety and Clinical Activity of Atezolizumab Plus Bevacizumab in Patients with Ovarian Cancer: A Phase Ib Study

Collaborators (11)

Lauren Fishbein

Laura Graham

Thomas J George

Richard Adams

Robert Lentz

Amit Mahipal

Eric Konnick

Patrick M. Forde

Alexis Leal

Nicole Simone

Shaikh Atif

Make your next move.